The European Medicines Agency recommended the antihemorrhagic drug eltrombopag to treat forms of thrombocytopenia and ...

Liver cancer is the sixth leading cause cancer death in the U.S. The most common type of liver cancer in adults is ...

While the treatment options for this aggressive type ... Mechanism of Action of the Hepatitis B and D Virus Cell Entry Inhibitor Bulevirtide Deciphered Apr. 10, 2024 — Over 12 million people ...

Earlier this month, Kezar Life Sciences announced that the mid-stage test of zetomipzomib in lupus nephritis had been placed ...

In 2020, an estimated 54 million adults in the U.S. were living with chronic pain. Over 25 percent of them were treating ...

Medically reviewed by Jay N. Yepuri, MDMedically reviewed by Jay N. Yepuri, MD Liver fibrosis is scarring of the liver. It has many causes, including alcohol-induced damage, infections, and diseases ...

Kezar (KZR) is discontinuing development of its drug zetomipzomib for the treatment of lupus nephritis so it can focus on ...

Kezar Life Sciences said on Thursday it would terminate its mid-stage trial studying its experimental drug in patients with active lupus nephritis and focus on the development of the drug in ...

By Dr. Joseph Kim University of Kentucky Liver cancer is the sixth leading cause cancer death in the U.S. The most common ...

Liver cancer is the sixth-leading cause cancer death in the U.S. The most common type of liver cancer in adults is ...

PursueCare, a leader in virtual addiction treatment, today announced the rollout of RESET ® and RESET-O ® , the only FDA-authorized prescription digital therapeutics (PDTs) for substance use disorder ...

As loosened rules for telemedicine are set to expire, Andrew Talal and Joshua Lynch discuss its importance and future in the delivery of health care services.